Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
Systemic Lupus Erythematosus (SLE) pathology has long been associated with an increased Epstein-Barr Virus (EBV) seropositivity, viremia and cross-reactive serum antibodies specific for both virus and self. It has therefore been postulated that EBV triggers SLE immunopathology, although the mechanism remains elusive. Here, we investigate whether frequent peaks of EBV viral load in SLE patients are a consequence of dysfunctional anti-EBV CD8+ T cell responses. Both inactive and active SLE patients (n = 76 and 42, respectively), have significantly elevated EBV viral loads (P = 0.003 and 0.002, respectively) compared to age- and sex-matched healthy controls (n = 29). Interestingly, less EBV-specific CD8+ T cells are able to secrete multiple cytokines (IFN-γ, TNF-α, IL-2 and MIP-1β) in inactive and active SLE patients compared to controls (P = 0.0003 and 0.0084, respectively). Moreover, EBV-specific CD8+ T cells are also less cytotoxic in SLE patients than in controls (CD107a expression: P = 0.0009, Granzyme B release: P = 0.0001). Importantly, cytomegalovirus (CMV)-specific responses were not found significantly altered in SLE patients. Furthermore, we demonstrate that EBV-specific CD8+ T cell impairment is a consequence of their Programmed Death 1 (PD-1) receptor up-regulation, as blocking this pathway reverses the dysfunctional phenotype. Finally, prospective monitoring of lupus patients revealed that disease flares precede EBV reactivation. In conclusion, EBV-specific CD8+ T cell responses in SLE patients are functionally impaired, but EBV reactivation appears to be an aggravating consequence rather than a cause of SLE immunopathology. We therefore propose that autoimmune B cell activation during flares drives frequent EBV reactivation, which contributes in a vicious circle to the perpetuation of immune activation in SLE patients.
Vyšlo v časopise:
Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002328
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002328
Souhrn
Systemic Lupus Erythematosus (SLE) pathology has long been associated with an increased Epstein-Barr Virus (EBV) seropositivity, viremia and cross-reactive serum antibodies specific for both virus and self. It has therefore been postulated that EBV triggers SLE immunopathology, although the mechanism remains elusive. Here, we investigate whether frequent peaks of EBV viral load in SLE patients are a consequence of dysfunctional anti-EBV CD8+ T cell responses. Both inactive and active SLE patients (n = 76 and 42, respectively), have significantly elevated EBV viral loads (P = 0.003 and 0.002, respectively) compared to age- and sex-matched healthy controls (n = 29). Interestingly, less EBV-specific CD8+ T cells are able to secrete multiple cytokines (IFN-γ, TNF-α, IL-2 and MIP-1β) in inactive and active SLE patients compared to controls (P = 0.0003 and 0.0084, respectively). Moreover, EBV-specific CD8+ T cells are also less cytotoxic in SLE patients than in controls (CD107a expression: P = 0.0009, Granzyme B release: P = 0.0001). Importantly, cytomegalovirus (CMV)-specific responses were not found significantly altered in SLE patients. Furthermore, we demonstrate that EBV-specific CD8+ T cell impairment is a consequence of their Programmed Death 1 (PD-1) receptor up-regulation, as blocking this pathway reverses the dysfunctional phenotype. Finally, prospective monitoring of lupus patients revealed that disease flares precede EBV reactivation. In conclusion, EBV-specific CD8+ T cell responses in SLE patients are functionally impaired, but EBV reactivation appears to be an aggravating consequence rather than a cause of SLE immunopathology. We therefore propose that autoimmune B cell activation during flares drives frequent EBV reactivation, which contributes in a vicious circle to the perpetuation of immune activation in SLE patients.
Zdroje
1. JamesJAHarleyJBScofieldRH 2001 Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 13 370 376
2. MunzCLunemannJDGettsMTMillerSD 2009 Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9 246 258
3. EvansASRothfieldNFNiedermanJC 1971 Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet 1 167 168
4. AlspaughMAHenleGLennetteETHenleW 1981 Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 67 1134 1140
5. BarzilaiORamMShoenfeldY 2007 Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 19 636 643
6. PooleBDScofieldRHHarleyJBJamesJA 2006 Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39 63 70
7. VaughanJHValbrachtJRNguyenMDHandleyHHSmithRS 1995 Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 95 1306 1315
8. SabbatiniADolcherMPMarchiniBBombardieriSMiglioriniP 1993 Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus. J Rheumatol 20 1679 1683
9. HjalgrimHAsklingJRostgaardKHamilton-DutoitSFrischM 2003 Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349 1324 1332
10. ThackerELMirzaeiFAscherioA 2006 Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59 499 503
11. GrossAJHochbergDRandWMThorley-LawsonDA 2005 EBV and systemic lupus erythematosus: a new perspective. J Immunol 174 6599 6607
12. KangIQuanTNolascoHParkSHHongMS 2004 Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172 1287 1294
13. MoonUYParkSJOhSTKimWUParkSH 2004 Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 6 R295 302
14. O'ReillyRJSmallTNPapadopoulosELucasKLacerdaJ 1997 Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev 157 195 216
15. WucherpfennigKWStromingerJL 1995 Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80 695 705
16. LunemannJDJelcicIRobertsSLutterottiATackenbergB 2008 EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205 1763 1773
17. McClainMTRappECHarleyJBJamesJA 2003 Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J Med Virol 70 253 257
18. MasciaMTSandriGGuerzoniCRoncagliaRMantovaniG 2008 Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis. Clin Exp Rheumatol 26 1034 1039
19. TsokosGCMagrathITBalowJE 1983 Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol 131 1797 1801
20. BernerBRTary-LehmannMYonkersNLAskariADLehmannPV 2005 Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Cell Immunol 235 29 38
21. BettsMRBrenchleyJMPriceDADe RosaSCDouekDC 2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78
22. DayCLKaufmannDEKiepielaPBrownJAMoodleyES 2006 PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 350 354
23. BarberDLWherryEJMasopustDZhuBAllisonJP 2006 Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 682 687
24. PosnettDN 2008 Herpesviruses and autoimmunity. Curr Opin Investig Drugs 9 505 514
25. RiveroSJDiaz-JouanenEAlarcon-SegoviaD 1978 Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 21 295 305
26. HrycekAKusmierzDMazurekUWilczokT 2005 Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38 487 491
27. JuryECFlores-BorjaFKalsiHSLazarusMIsenbergDA 2010 Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol 40 569 578
28. MoultonVRTsokosGC 2010 Alternative splicing factor/ splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex. J Biol Chem 285 12490 12496
29. SauceDAlmeidaJRLarsenMHaroLAutranB 2007 PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 21 2005 2013
30. ProkuninaLCastillejo-LopezCObergFGunnarssonIBergL 2002 A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32 666 669
31. QuanTERomanRMRudengaBJHolersVMCraftJE 2010 Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 62 1693 1701
32. BanchereauJPascualV 2006 Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 383 392
33. BennettLPaluckaAKArceECantrellVBorvakJ 2003 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197 711 723
34. BlancoPPaluckaAKGillMPascualVBanchereauJ 2001 Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 1540 1543
35. JacobiAMReiterKMackayMAranowCHiepeF 2008 Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 58 1762 1773
36. Ten BoekelESiegertCEVrielinkGJVan DamVCCeelenA 2007 Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies. J Clin Immunol 27 467 476
37. JamesJAKaufmanKMFarrisADTaylor-AlbertELehmanTJ 1997 An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100 3019 3026
38. McClainMTHeinlenLDDennisGJRoebuckJHarleyJB 2005 Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11 85 89
39. HochbergMC 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 1725
40. BombardierCGladmanDDUrowitzMBCaronDChangCH 1992 Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35 630 640
41. HislopADAnnelsNEGudgeonNHLeeseAMRickinsonAB 2002 Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195 893 905
42. SauceDLarsenMCurnowSJLeeseAMMossPA 2006 EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood 108 11 18
43. ScotetEDavid-AmelineJPeyratMAMoreau-AubryAPinczonD 1996 T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 184 1791 1800
44. WillsMRCarmichaelAJMynardKJinXWeekesMP 1996 The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70 7569 7579
45. DebackCGeliJAit-ArkoubZAngleraudFGautheret-DejeanA 2009 Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels. J Virol Methods 159 291 294
46. RoedererMNozziJLNasonMC 2011 SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79 167 174
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis
- Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- Herpesvirus Telomerase RNA (vTR) with a Mutated Template Sequence Abrogates Herpesvirus-Induced Lymphomagenesis